Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
10/1997
10/29/1997EP0802897A1 Novel compounds
10/29/1997EP0802796A1 Chicken anaemia agent broiler vaccine
10/29/1997EP0802794A1 Modulators of pneumococcal adherence to pulmonary and vascular cells and diagnostic and therapeutic applications
10/29/1997EP0639069B1 Galenic form for ocular administration and process for the preparation of same
10/29/1997EP0637976B1 Medicament for disinfection of the oral cavity
10/29/1997EP0636136B1 2-aminosugar derivatives of macrolides
10/29/1997EP0493380B1 Method and compositions for noninvasive dose-to-effect administration of lipophilic drugs
10/29/1997CN1163615A Bicyclic oxazine and thiazine oxazolidinone antibacterials
10/29/1997CN1163614A Novel carbapenem derivative
10/29/1997CN1163401A Fully automatic hemacytometer reagent and preparing method
10/28/1997US5681965 Alpha-phenyl tert-butyl nitrone and derivatives as free radical scavengers treating aging, oxidative tissue damage
10/28/1997US5681944 Hybridizes with the translation initiation region of the e6 or e7 messanger rna of human papilloma virus such that replication of virus is inhibited
10/28/1997US5681941 Substituted purines and oligonucleotide cross-linking
10/28/1997US5681940 Sugar modified nucleosides and oligonucleotides
10/28/1997US5681862 Ionene polymers as microbicides
10/28/1997US5681849 Pharmaceutical composition for topical applications
10/28/1997US5681838 Substituted amino compounds, their preparation and their use as inhibitors of thrombocyte-aggregation
10/28/1997US5681831 Method of treating viral and retroviral infections including HIV by administration of N6 -(Δ)2 -isopentenyl) adenosine or an analogue thereof
10/28/1997US5681829 Class of phosphocholine derivatives having antifungal activity
10/28/1997US5681824 Substituted liposaccharides useful in the treatment and prevention of endotoxemia
10/28/1997US5681736 Culturing in vitro in a culture medium containing bile or bile acid or salt; air or a gas mixture; a divalent chelate compound in a preferential temperature
10/28/1997US5681716 Nucleic acid sequences from Salmonella typhi for in vitro diagnosis in foodstuffs
10/28/1997US5681570 A conjugate of capsular polysaccharide of streptococcus strain linked to p6 outer membrane protein of the haemophillus influenza strain
10/28/1997US5681565 Coating with immunoglobulins, antibodies
10/23/1997WO1997039355A1 Pharmaceutical grade botanical drugs
10/23/1997WO1997039128A2 Use of a modified rev-responsive element (rre) in methods and compositions for combatting hiv infection
10/23/1997WO1997039127A1 Hybrid interferon compositions and methods of use
10/23/1997WO1997039126A1 Novel rantes homolog from prostate
10/23/1997WO1997039123A2 Secreted proteins
10/23/1997WO1997039119A1 Mammalian genes involved in viral infection and tumor suppression
10/23/1997WO1997039111A1 Compositions containing bacteriophages and methods of using bacteriophages to treat infections
10/23/1997WO1997039024A1 Cyclic prodrugs of peptides and peptide nucleic acids having improved metabolic stability and cell membrane permeability
10/23/1997WO1997039022A1 Novel compounds
10/23/1997WO1997039017A1 STREPTOCOCCUS PNEUMONIAE HISTIDYL tRNA SYNTHETASE
10/23/1997WO1997039016A1 NOVEL LysS PROTEINS FROM STREPTOCOCCUS PNEUMONIAE
10/23/1997WO1997039015A1 STREPTOCOCCUS PNEUMONIAE TYROSYL-tRNA SYNTHETASE
10/23/1997WO1997039014A1 STREPTOCOCCUS PNEUMONIAE ASPARTYL tRNA SYNTHETASE
10/23/1997WO1997039013A1 STREPTOCOCCUS PNEUMONIAE ALANYL tRNA SYNTHETASE
10/23/1997WO1997039012A1 STREPTOCOCCUS PNEUMONIAE METHIONYL tRNA SYNTHETASE
10/23/1997WO1997039011A1 STREPTOCOCCUS PNEUMONIAE ISOLEUCYL tRNA SYNTHETASE
10/23/1997WO1997038999A1 Acridone-derived compounds useful as antineoplastic and antiretroviral agents
10/23/1997WO1997038992A1 Piperidinylpyramidine derivatives
10/23/1997WO1997038986A1 Substituted benzenesulfonamide derivatives as prodrugs of cox-2 inhibitors
10/23/1997WO1997038724A1 New indications for the use as medicaments of multipotent parapox immunity inducers from attenuated, non-immunogenic pox viruses or parapox viruses
10/23/1997WO1997038722A1 Novel compounds
10/23/1997WO1997038721A1 Novel compounds
10/23/1997WO1997038720A1 Novel compounds
10/23/1997WO1997038719A1 Novel compounds
10/23/1997WO1997038717A1 Novel compounds
10/23/1997WO1997038716A1 Novel compounds
10/23/1997WO1997038715A1 Novel compounds
10/23/1997WO1997038714A1 Novel compounds
10/23/1997WO1997038706A1 Glycopeptide compounds
10/23/1997WO1997038703A1 Chimeric isoprenoid synthases and uses thereof
10/23/1997WO1997038695A1 Dhea combination therapy
10/23/1997WO1997038689A2 Enteric-coated pharmaceutical compositions of mycophenolate
10/23/1997WO1997038665A2 Inhibitors of farnesyl-protein transferase
10/23/1997WO1997034137A3 Methods of the identification of pharmaceutically active compounds
10/23/1997WO1997031114A3 Polynucleotides and aminoacid sequences from staphylococcus aureus
10/23/1997WO1997031019A3 Antipathogenic peptides and compositions comprising them
10/23/1997WO1997022368A3 Covalent lipid-phosphono-carboxylic acid conjugates and application thereof as antiviral medicaments
10/23/1997DE19615803A1 CELO-Virus CELO virus
10/23/1997CA2252426A1 Pharmaceutical grade botanical drugs
10/23/1997CA2252225A1 Use of a modified rev-responsive element (rre) in methods and compositions for combatting hiv infection
10/23/1997CA2252082A1 Hybrid interferon compositions and methods of use
10/23/1997CA2251818A1 Mammalian genes involved in viral infection and tumor suppression
10/23/1997CA2251733A1 Dhea combination therapy
10/23/1997CA2251724A1 Compositions containing bacteriophages and methods of using bacteriophages to treat infections
10/23/1997CA2251115A1 Novel rantes homolog from prostate
10/23/1997CA2250943A1 Piperidinylpyrimidine derivatives
10/23/1997CA2249601A1 Inhibitors of farnesyl-protein transferase
10/23/1997CA2219151A1 Cyclic prodrugs of peptides and peptide nucleic acids having improved metabolic stability and cell membrane permeability
10/22/1997EP0802199A2 Covalently bound dimers of glycopetide antibiotics
10/22/1997EP0802196A1 Alkylenediamine derivative, antiulcer drug, and antibacterial drug
10/22/1997EP0801946A2 Use of salicin as agent against irritation in cosmetic and topical dermatological compositions
10/22/1997EP0801945A2 Use of ferulic acid glucosides as agents against irritation in cosmetic or topical dermatological compositions
10/22/1997EP0801656A1 Induction of cytotoxic t-lymphocyte responses
10/22/1997EP0801655A1 Basic proline-amide derivatives of ge 2270 and ge 2270-like antibiotics
10/22/1997EP0801649A2 Hydroxylamine derivatives useful for enhancing the molecular chaperon production and the preparation thereof
10/22/1997EP0801640A1 2,5-diamino-3,4-disubstituted-1,6-diphenylhexane isosteres comprising benzamide, sulfonamide and anthranilamide subunits and methods of using same
10/22/1997EP0698041B1 Synthetic aglucodalbaheptide antibiotics
10/22/1997CN1162918A Depressant of functions developed by molecule
10/22/1997CN1162455A Chinese medical prescription for foot and mouth disease
10/22/1997CN1162448A Prescription for curing gonorrhea and preparation thereof
10/22/1997CN1162446A Bathing preparation for pets against diseases and method for preparation
10/22/1997CN1036196C 1,3-Oxatholane nucleoside analogues
10/21/1997US5679790 Antibiotics, bactericides
10/21/1997US5679774 DNA sequences of the EBV genome, recombinant DNA molecules, processes for preparing EBV-related antigens, diagnostic compositions and pharmaceutical compositions containing said antigens
10/21/1997US5679768 Epitopic regions of pneumococcal surface protein A
10/21/1997US5679689 Bactericides
10/21/1997US5679688 Quinaldoyl-amine derivatives of oxo-and hydroxy-substituted hydrocarbons
10/21/1997US5679675 Bactericides
10/21/1997US5679653 Diagnosis and treatment of bacterial dystentery
10/21/1997US5679564 Culturing in a medium with bile, bile acid or its salts and a divalent cation chelator; heating in air or a gas mixture
10/21/1997US5679530 Immunogenic complex of isolated polypeptides of specific amino acid sequence to a keyhole lampet hemocyanin
10/21/1997US5679374 Dispersion of lipid vesicles capable of penetrating into layers of skin and containing antimicrobial agents, n-(1-oxyl-2,2,6,6-tetramethyl-4-piperidyl)-n-dimethyl-n-hydro xyethylammonium iodide, antiinflammatory agents, retinol
10/21/1997US5679352 Synthetic Haemophilus influenzae conjugate vaccine
10/21/1997US5679349 Vaccine design and production
10/21/1997US5679348 Applying a local therapeutic or prophylactic vaccine for the eye comprising one or more recombinant hsv-1 glycoproteins
10/21/1997US5679339 Method of using IL-11 for treating spondyloarthropies
1 ... 1570 1571 1572 1573 1574 1575 1576 1577 1578 1579 1580 1581 1582 1583 1584 1585 1586 1587 1588 1589 1590 ... 1798